CLINICAL_TRIALS
trial_result
· 2009-11-17
Clinical Trial Update: Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab [Phase 3]
Summary
Phase 3 trial update evaluating certolizumab in Crohn's disease patients who lost response or cannot tolerate infliximab; results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB Pharma | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-11-17